Albumin & Creatinine Tests Market Analysis

  • Report ID: 4665
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Albumin & Creatinine Tests Market Analysis

Type (Blood & Urine Creatinine, Urine Albumin, Glycated Albumin)

The global albumin & creatinine tests market is segmented and analyzed for demand and supply by type into blood & urine creatinine, urine albumin, and glycated albumin. Out of these, the urine albumin segment is estimated to gain the largest market share over the projected time frame. Albuminuria (urine albumin) is a sign of kidney disease and is characterized by excessive albumin levels in the urine. It has been observed that the proportion of patients who have urine albumin laboratory results is increasing over time in every age group, along with the resulting increase in consumer demand for convenient and rapid urine tests, which is expected to drive segment growth throughout the forecast period. As a result of a survey conducted in the United States between 2005 and 2019, it was found that the percentage of people with urine albumin results increased from 6%–16% among 40–49-year-olds; 11%–22% among 50–59-year-olds, 12%–27% among 60-69-year-olds and 10%–25% for those older than 70.

Product (Analyzers, Cartridges (PoC, Tabletop), Dipsticks, Kits, Reagents)

The global albumin & creatinine tests market is also segmented and analyzed for demand and supply by-product into analyzers, cartridges (POC, tabletop), dipsticks & kits, and reagents. Amongst these segments, the dipsticks & kits segment is expected to garner a significant share by the end of 2037. The albumin & creatinine tests are used to detect kidney damage, and the kits for these tests are becoming more popular as they are less expensive and easier to use than traditional analyzers and cartridges. Moreover, a urine dipstick test is a quick and easy way to test for the presence of various substances in the urine, such as protein, blood, and sugar. The results are usually available between 60 and 120 seconds after an appointment with the doctor. Therefore, such factors are expected to fuel the growth of the segment in the future.

Our in-depth analysis of the global market includes the following segments:

     By Product

  • Analyzers
  • Cartridges (PoC, Tabletop)
  • Dipsticks & Kits
  • Reagents

       By Type

  • Blood & Urine Creatinine
  • Urine Albumin
  • Glycated Albumin

       By End User

  • Hospital
  • Diagnostic & Research Labs
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4665
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of albumin & creatinine tests is assessed at USD 5.65 billion.

The albumin & creatinine tests market size was over USD 4.25 billion in 2024 and is projected to reach USD 41.23 billion by 2037, witnessing around 19.1% CAGR during the forecast period i.e., between 2025-2037. Rising rates of hypoalbuminemia and hypovolemia and the rising geriatric population will boost the market growth.

North America industry is set to account for largest revenue share by 2037, attributed to increasing prevalence of chronic diseases and rise in healthcare spending by general population.

The major players in the market are Danaher Corporation, FUJIFILM Wako Pure Chemical Corporation, Nova Biomedical, Ortho Clinical Diagnostics, PromoCell GmbH, Siemens Healthineers company, Sysmex Corporation, Teco Diagnostics, Thermo Fisher Scientific Holdings, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample